Hemodialysis and Peritoneal Dialysis Market

The report "Hemodialysis & Peritoneal Dialysis Market by Product (Hemodialysis Equipment, Dialysates, PD Machine, Consumables), Modality (CAPD, APD, SDHD, Conventional HD, Nocturnal HD), Disease Indication (CKD, ESRD, AKI), End User, Region - Global Forecast to 2031" is projected to reach USD 141.5 billion by 2031 from USD 102.7 billion in 2026, growing at a CAGR of 6.6% during the forecast period.

Browse 480 market data Tables and 78 Figures spread through 500 Pages and in-depth TOC on "Hemodialysis & Peritoneal Dialysis Market by Product (Hemodialysis Equipment, Dialysates, PD Machine, Consumables), Modality (CAPD, APD, SDHD, Conventional HD, Nocturnal HD), Disease Indication (CKD, ESRD, AKI), End User, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html

The primary force behind this growth is the rising prevalence of chronic kidney disease and end-stage renal disease, driven by increasing rates of type 2 diabetes, hypertension, and aging populations across both developed and emerging markets. Growing adoption of home-based dialysis therapies, supported by CMS reimbursement expansions in the US and government-backed dialysis access programs in Asia Pacific and Latin America, is broadening the global patient base. Improved dialysis machine technology, including high-volume hemodiafiltration systems and AI-assisted therapy management platforms, is accelerating clinical adoption across in-center and home care settings.

The in-center hemodialysis services segment is expected to account for the largest share of the hemodialysis and peritoneal dialysis market during the forecast period.

In-center hemodialysis services held the largest share of the HD services market in 2026. The segment leads because the vast majority of patients with prevalent ESRD receive treatment at licensed dialysis centers, where access to clinical staff, equipment maintenance, and emergency response is readily available. Dialysis chains in the US, Europe, and Asia Pacific have invested heavily in expanding center capacity to accommodate growing patient enrollment, reinforcing the structural dominance of this channel. The in-center model also remains the standard of care for patients with significant comorbidities, newly incident ESRD patients, and AKI patients requiring acute support. In-center hemodialysis services are projected to grow at a robust CAGR during 2026–2031, supported by continued expansion of the facility network and stable reimbursement under the CMS ESRD Prospective Payment System.

The end-stage renal disease segment is projected to register the highest CAGR in the hemodialysis and peritoneal dialysis market during the forecast period.

End-stage renal disease (ESRD) is the largest disease indication in the hemodialysis and peritoneal dialysis market. ESRD requires lifelong renal replacement therapy in the absence of a transplant, creating a structurally recurring and growing demand base for both hemodialysis and peritoneal dialysis products and services. The convergence of rising global diabetes prevalence, hypertension burden, and aging demographics is adding net new ESRD patients faster than transplant availability can offset. Improved early detection programs are enrolling more CKD stage 4 and 5 patients in the ESRD registry, particularly in India, China, and sub-Saharan Africa. This combination of structural incidence growth and expanding market access in high-burden regions positions the ESRD indication as the primary volume driver through 2031.

The Asia Pacific region is expected to register the highest CAGR in the hemodialysis and peritoneal dialysis markets during the forecast period.

The Asia Pacific is the fastest-growing regional market during 2026–2031. China and India are the primary growth engines, supported by government-funded universal dialysis access programs, including the Pradhan Mantri National Dialysis Programme in India, and by volume-based procurement policies in China, which have expanded patient enrollment in tier-2 and tier-3 cities. Increasing healthcare expenditure, a growing private dialysis center sector in Southeast Asia, and the entry of global manufacturers with competitively priced systems for emerging markets are adding to regional momentum. North America remains the largest regional market, accounting for approximately 46.2% of global market share in 2026, supported by more than 808,000 ESRD patients and a mature reimbursement framework under the CMS ESRD Prospective Payment System.

Key Market Players

The major market players covered in the report include Fresenius Medical Care (Germany), Vantive (US), B. Braun (Germany), Nipro Corporation (Japan), and Nikkiso Co., Ltd. (Japan), among others.

Don’t miss out on business opportunities in Hemodialysis & Peritoneal Dialysis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com